FRAME posters to feature at WC11 Virtual Congress

FRAME is pleased to be taking part in the 2021 World Congress on Alternatives and Animal Use in the Life Sciences (WC11) this week.

The Congress is one of the leading global conferences discussing the replacement of animal use in science. This year’s event (WC11), which runs from 23 August to 2 September, is hosted online and provides a unique platform for discussions about animal replacement amongst scientists across the world.

The theme for WC11: ‘3Rs in transition: from development to application,’ is inspired by the progress made in the range of technologies available to support non-animal test models and the 3Rs. The Congress’ content is based around four key themes: innovative technologies, safety, disease, and ethics, welfare and regulation.

On Friday 27 August from 5pm UK time, two posters by FRAME will be featured in one of the event’s dedicated poster sessions:

• Accelerating the uptake of non-animal methods in bioscience research system dynamic and individual responsibility| By FRAME CEO, Celean Camp
• Is it possible to stem the tide of GA animal use in biomedical research? | By FRAME Education & Outreach Manager, Amy Beale

Attendees who would like to discuss the content of FRAME’s posters are invited to contact us via the Congress platform or email us at: hello@frame.org.uk

WC11 is set to feature a range of insightful sessions and talks. FRAME Chair of Trustees and XCellR8 founder and CEO, Dr Carol Treasure will deliver a number of sessions on moving towards animal-product-free in vitro systems, as well as a Unilever-sponsored session on Thursday 2 September at 12:30pm on ‘Optimising in vitro methods through removal of serum components.’ This session will share recent results from a collaboration between XCellR8 and Unilever to develop defined media versions of existing in vitro test methods, as well as highlight the opportunity to optimise in vitro test systems through removal of serum components.

The WC11 platform is live and open to attendees here.